Kurata Lance's most recent trade in Arcturus Therapeutics Holdings Inc was a trade of 60,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 16, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcturus Therapeutics Hold... | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
Arcturus Therapeutics Hold... | Kurata Lance | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
Arcturus Therapeutics Hold... | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
Arcturus Therapeutics Hold... | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
Arcturus Therapeutics Hold... | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
Arcturus Therapeutics Hold... | Lance Kurata | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 90,000 | 90,000 | - | - | Stock Option (right to buy) |